TRACY NICHOLAS: Open Payments
NPI 1003095977 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 10 payments from 8 companies in 2025. Trend: 2023 $66 · 2024 $89 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| TriSalus Life Sciences, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| Hydrofera LLC | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
Products named: REZDIFFRA, IQIRVO, PURIFIED CORTROPHIN GEL, XIFAXAN, TRINAV INFUSION SYSTEM, MAVYRET, HYDROFERA BLUE, OCALIVA.
Industry payments across GA — which companies pay providers there.
